Balchem Corp (BCPC) stock
Close on Nov 12, 2026Market cap $5.48BP/E 32.5Yield 0.56%
Balchem Corp grew revenue 9.4% to $1.11B over the twelve months to Sep 30, 2026. Operating income rose 12.3% to $229.57M, moving the operating margin from 20.2% to 20.7%. At the latest close the market valued the company at $5.48B, 32.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $5.48B
- P/E ratio
- 32.5
- Price to sales
- 4.94
- Price to book
- 4.13
- Dividend yield
- 0.56%
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.11B
- Net income
- $170.85M
- EPS, diluted
- $5.31
- Book value per share
- $41.42
- Diluted shares
- 32M
Trading
- Next earnings
- Feb 19, 2027 (estimated, before the open)
- Previous close
- $173.30
- Open
- $174.58
- Day's range
- $172.03 – $175.50
- Volume
- 178,678
- Average volume (20 days)
- 324,955
- Index membership
- S&P SmallCap 600, Russell 2000, Russell 3000
- Beta (5 years)
- 0.75
- 52-week range
- $147.18 – $186.15
- RSI (14 days)
- 51.2
- Volatility (1 year)
- 21.6%
- Relative volume
- 0.85×
- WACC
- 8.6%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BCPC | S&P 500 | Difference | BCPC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +2.5% | -2.7% | +5.2 pts | ||
| 3 months | -4.1% | -1.7% | −2.4 pts | ||
| Year to date | +12.4% | +11.9% | +0.5 pts | ||
| 1 year | +10.3% | +12.0% | −1.7 pts | ||
| 3 years | +48.1% | +78.2% | −30.0 pts | +14.0% | +21.2% |
| 5 years | +7.1% | +73.2% | −66.1 pts | +1.4% | +11.6% |
| 10 years | +133.2% | +309.6% | −176.5 pts | +8.8% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Balchem filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Results
About Balchem
Chemicals & Allied Products
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products across three primary segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The company provides nutrient solutions such as choline, mineral amino acid chelates, specialty vitamins, and food systems to food, beverage, and dietary supplement manufacturers. For animal agriculture and companion pets, it supplies microencapsulated nutrients and choline chloride to livestock and feed producers. In its specialty segment, Balchem packages and distributes performance gases, including ethylene oxide for medical device sterilization and fumigants for agricultural processors, alongside foliar crop nutrients for farmers.
Company profile, executives and historyBalchem stock: common questions
What is Balchem's stock price?
BCPC closed at $172.35 on Nov 12, 2026, down 0.55% on the day. Over the past 52 weeks it traded between $147.18 and $186.15.
What is Balchem's market cap?
Balchem was worth $5.48B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is BCPC's P/E ratio?
BCPC trades at 32.5 times earnings, based on diluted earnings per share of $5.31 over the twelve months to Sep 30, 2026.
How much revenue does Balchem make?
Balchem reported revenue of $1.11B for the twelve months to Sep 30, 2026, up 9.4% from a year earlier.
Does Balchem pay a dividend?
Yes. Balchem paid $0.96 per share over the last twelve months, a yield of 0.56% at the latest price, and has raised its annual dividend 3 years in a row.
When does Balchem report earnings next?
Balchem is expected to report Q4 FY2026 results on Feb 19, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has BCPC stock performed over the past year?
Including dividends, BCPC returned +10.3% over the past year, against +12.0% for the S&P 500.
How many BCPC shares are sold short?
1M shares were sold short at the latest FINRA report, 1.60% of the float, or 1.5 days of average trading volume.
Who are Balchem's competitors?
Companies most similar to Balchem by business, industry and size include IOSP, NGVT, FMC, PRM, ECVT.
See a number that looks wrong?